SL
CRL icon

Savior LLC’s Charles River Laboratories CRL Stock Holding History

Savior LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-86
Closed -$32K – 312
2021
Q2 		$32K Hold
86
– – 0.03% 214
2021
Q1 		$25K Hold
86
– – 0.03% 247
2020
Q4 		$21K Hold
86
– – 0.02% 277
2020
Q3 		$19K Hold
86
– – 0.02% 263
2020
Q2 		$15K Hold
86
– – 0.02% 273
2020
Q1 		$11K Hold
86
– – 0.01% 301
2019
Q4 		$13K Buy
+86
New +$11.9K 0.02% 380

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Savior LLC's CRL Position: Q3 2021 in Review

Savior LLC sold out of Charles River Laboratories (CRL) in Q3 2021, closing a stake of 86 shares — an estimated $32K sold.

Savior LLC first reported a position in CRL in Q4 2019 and held it in 7 quarters. The position peaked at $32K in Q2 2021. 677 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

  • Savior LLC reported no remaining Charles River Laboratories position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 86 Charles River Laboratories shares in Q3 2021, an estimated $32K.
  • Savior LLC first reported a position in Charles River Laboratories in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Charles River Laboratories position peaked at $32K in Q2 2021.
  • 677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.